Health

Vital Materials Released Quantum Flux Photon Counting CT (PCCT) Full Vertical Integration Technology

BEIJING, Aug. 20, 2025 /PRNewswire/ -- From August 15-17, the 31st China International Medical Equipment Exhibition and Scientific Conference (China-Hospeq…

3 months ago

Nilesh Shah joins Illumina as Head of Region, AMEA

SINGAPORE, Aug. 19, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced…

3 months ago

ITM to Present New Subgroup Analysis Data from the COMPETE Trial at ESMO 2025 and Host an Educational Event for Healthcare Professionals

Garching / Munich, Germany, August 19, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced…

3 months ago

Scientists Discuss the Recent CancerVax Breakthrough

The Company's scientific team describes how they successfully disguised cancer cells and tricked immune cells into attacking them and reveals…

3 months ago

openRxiv names Dr. Tracy Teal first CEO to advance open science

Scientist and nonprofit leader who previously led The Carpentries and Dryad to lead the organization that oversees bioRxiv and medRxiv.…

3 months ago

Ansell Receives Frost & Sullivan’s 2025 Global Sustainable Hospital Supplies Company of the Year Award

Ansell is recognised for its leadership in hospital supply sustainability, visionary innovation, and customer impact on a global scale. SAN…

3 months ago

Virbac:: Paul Martingell’s compensation terms

The board of directors of Virbac specifies Paul Martingell's compensation terms as chief executive officer. The board of directors, acting…

3 months ago

Clarity Health Care is Coming to Malvern

MELBOURNE, Australia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Clarity Health Care, a leading provider of multidisciplinary mental health services, is…

3 months ago

BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering

Los Angeles, CA, Aug. 15, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with…

3 months ago

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

    - Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial - Expanded global IP protection by securing…

3 months ago